Grace Therapeutics updates corporate presentation in routine 8-K

Grace Therapeutics, Inc.

Filed an updated corporate presentation as Exhibit 99.1 on April 27, 2026.
No specific financial or operational changes disclosed in the filing.
Presentation content not excerpted; unable to identify new information.

item 8.01 item 9.01

Grace Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-26-016834

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.